Novavax Aktie
5,76
EUR
+0,34
EUR
+6,27
%
6,47
USD
+0,25
USD
+3,94
%
Novavax jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 6 | 1 | 1 | 145,86 GBP | +5,03% |
| Bayer | 2 | 7 | 0 | 27,36 EUR | -10,95% |
| BioNTech (ADRs) | 4 | 2 | 0 | 135,67 USD | +41,93% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| Fresenius Medical Care (FMC) St. | 3 | 4 | 3 | 47,22 EUR | +14,78% |
| Fresenius SE & Co. KGaA (St.) | 7 | 2 | 0 | 52,57 EUR | +11,50% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Inovio Pharmaceuticals Inc | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 4 | 2 | 101,38 CHF | -1,52% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 4 | 0 | 29,33 USD | +17,13% |
| Roche AG (Genussschein) | 3 | 2 | 3 | 280,57 CHF | -10,16% |
| Sanofi S.A. | 8 | 1 | 0 | 107,38 EUR | +24,15% |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |